Skip to main content

US Makes New Alzheimer's Drug More Widely Accessible

By
US Makes New Alzheimer's Drug More Widely Accessible

Approximately 6.5 million Americans suffer from Alzheimer's (Representational)

The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

Leqembi, developed jointly by Japan's Eisai and Biogen of the United States, was shown in a clinical trial to modestly reduce cognitive decline among patients in the early stages of the disease.

But the study also raised concerns about side effects including brain bleeds and swelling.

Leqembi was initially granted "accelerated approval" by the Food and Drug Administration in January, which meant it was not broadly covered by the government-run Medicare program for people aged 65 and older.

Thursday's decision, which follows further study of the drug, means Medicare will now defray a large portion of treatment, initially listed by the makers at $26,500 per year.

"This confirmatory study verified that it is a safe and effective treatment for patients with Alzheimer's disease," senior FDA official Teresa Buracchio said in a statement.

Chiquita Brooks-LaSure, administrator of the agency that runs Medicare, added: "This is welcome news for the millions of people in this country and their families who are affected by this debilitating disease."

But people covered by Medicare will still need to meet 20 percent of the cost, or thousands of dollars, themselves.

Approximately 6.5 million Americans suffer from Alzheimer's, which is characterized by memory loss and declining mental acuity.

Leqembi, also known as lecanemab, is an antibody treatment that is injected into the brain every two weeks and works by reducing amyloid beta, a protein that builds into plaques and causes brain cells to die, as well as brain shrinkage.

The FDA's decision was welcomed by patient groups.

"This treatment, while not a cure, can give people in the early stages of Alzheimer's more time to maintain their independence and do the things they love," said Joanne Pike, Alzheimer's Association president and CEO.

"This gives people more months of recognizing their spouse, children and grandchildren."

Leqembi was the second Alzheimer's drug developed by Eisai and Biogen to receive approval. The first, Aduhelm, was approved in 2021 but the decision was highly controversial as the data about its efficacy was inconsistent.

In May, US drugmaker Eli Lilly announced its drug donanemab also significantly slowed cognitive decline associated with Alzheimer's, and would soon seek worldwide regulatory approval.

Alzheimer's disease accounts for 60 to 80 percent of dementia, according to the Alzheimer's Association. It progressively destroys thinking and memory, eventually robbing people of the ability to carry out the simplest of tasks.


 

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Adblock test (Why?)



from NDTV News- Special https://ift.tt/el0ais4 https://ift.tt/5WpcaKn
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Salaries Of 12700 Punjab Teachers Tripled After Regularisation

By
Punjab government has tripled the salaries of 12,700 teachers, who were regularised recently. Chandigarh: Punjab Chief Minister Bhagwant Mann on Tuesday said the salaries of 12,700 teachers, who were regularised recently, have been increased by up to three times. In a statement here, Mr Mann said these teachers will be known as associate teachers and special inclusive teachers, adding that they will be governed by a 'Policy for Welfare of Adhoc, Contractual, Temporary Teachers (Nation Builders) and other employees in the School Education Department'. Based on their educational qualifications and primary conditions for entry into services, their emoluments have been fixed up to the completion of 58 years in service. Mr Mann said these teachers will be entitled to an increment of 5 per cent on their salaries every year. The chief minister said BA pass education providers (associate teachers) who were hitherto getting Rs 9,500 per month will now get Rs 20,500 as an emolum...
Post a Comment
Read more

"Mandir" Tag To Health Centers Sparks Backlash In Ladakh

By
The new signages of Ayushman Health Centres raised eyebrows in Ladakh. Srinagar: The renaming of Ayushman Bharat Health and Wellness centers as Ayushman Arogya Mandir has sparked backlash in Ladakh. After red flag by Ladakh Buddhist Association, the BJP ruled Ladakh Autonomous Council has asked the Lieutenant Governor to "respect public sentiment". "I am taking the liberty to express my concerns, as well as of the public, regarding the recent renaming of the Ayushman Bharat Health and Wellness centers to Ayushman Arogya Mandir," Tashi Gyalson, Chairman cum Chief Executive Councilor of Ladakh Autonomous Hill Development Council, wrote to Lieutenant Governor, Brig (Retired) B.D. Mishra. "It has come to my attention that this change has generated significant resentment among the public, necessitating prompt attention and resolution," wrote Mr Gyalson. Referring to Health ministry directive, Mr Gyalson, who is also a senior BJP leader, said it was stip...
Post a Comment
Read more

Mob Attacks Hindu Procession In Maharashtra's Thane, Case Filed: Cops

By
The incident took place on Sunday night on Lodha Road, police said. (Representational) Thane: A mob of 50-60 persons was booked by Mira Bhayander Vasai Virar police in Thane district for allegedly assaulting a man who was part of a procession on the eve of the idol consecration of the Ram Temple in Ayodhya, an official said. The incident took place on Sunday night on Lodha Road and as per the complainant the mob armed with iron rods, sticks, bats shouted religious slogans and assaulted him when he was part of a procession comprising three vehicles and 10 two-wheelers, the official said. They vandalised the car with stones and sticks, the man said in his complaint to Naya Nagar police station. "A case of attempt to murder and other offences has been registered against a mob of 50-60 persons. Further probe is underway," the official added. (Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.) Adblock test (Wh...
Post a Comment
Read more